Last reviewed · How we verify

NCT03540732: FICE

Feeding With Indirect Calorimetry and Cycling in the Elderly

Status unknown NA Last updated 27 July 2023
What this trial tests

NA trial testing Indirect Calorimetry directed feeding. in Calorimetry, Indirect in 50 participants. Status unknown.

Timeline
6 November 2017
Primary endpoint
30 June 2024
31 December 2024

Quick facts

Lead sponsorNational University Hospital, Singapore
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment50
Start date6 November 2017
Primary completion30 June 2024
Estimated completion31 December 2024
Sites1 location across Singapore

Drugs / interventions tested

Conditions studied

Sponsor

National University Hospital, Singapore

Who can join

60 and older, any sex, with Calorimetry, Indirect or Exercise Therapy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to evaluate the effect of early exercise by cycle ergometry and early targeted feeding in reducing muscle atrophy and improve functional outcomes in the older critically ill patient.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Indirect calorimetry directed feeding and cycling in the older ICU population: a pilot randomised controlled trial.
    Elizabeth NSH, Yanni T, May LS, Fen TH, et al · · 2024 · cited 7× · PMID 38714926 · DOI 10.1186/s12871-024-02507-8

Verify or expand the search:

Other recruiting trials for Calorimetry, Indirect

Currently open trials in the same condition.

Other National University Hospital, Singapore trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03540732.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing